Premium
Altered Neurotrophin mRNA Levels in Peripheral Nerve and Skeletal Muscle of Experimentally Diabetic Rats
Author(s) -
Fernyhough Paul,
Diemel Lara T.,
Brewster Wendy J.,
Tomlinson David R.
Publication year - 1995
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1046/j.1471-4159.1995.64031231.x
Subject(s) - medicine , endocrinology , sciatic nerve , neurotrophin , skeletal muscle , neurotrophin 3 , soleus muscle , neurotrophic factors , nerve growth factor , streptozotocin , diabetes mellitus , brain derived neurotrophic factor , biology , receptor
The levels of neurotrophin mRNA in sensory ganglia, sciatic nerve, and skeletal muscle were measured in the streptozotocin‐diabetic rat using northern blotting. Periods of diabetes of 4, 6, and 12 weeks significantly elevated brain‐derived neurotrophic factor (BDNF) mRNA levels in soleus muscle compared with age‐matched controls, the increase being highest at 6 weeks. At all time periods studied, the levels of nerve growth factor (NGF) mRNA in soleus muscle were decreased by 21–47%. Following 12 weeks of diabetes, BDNF mRNA levels were increased approximately two‐to threefold in L4 and L5 dorsal root ganglia (DRG), and in sciatic nerve, NGF mRNA levels were raised 1.65‐fold. Intensive insulin treatment of diabetic rats for the final 4 weeks of the 12‐week period of diabetes reversed the up‐regulation of BDNF mRNA in DRG and muscle and NGF mRNA in sciatic nerve. All diabetes‐induced changes in neurotrophin mRNA were not paralleled by similar alterations in the levels of β‐actin mRNA in muscle and nerve, or of GAP‐43 mRNA in DRG and nerve. It is proposed that the up‐regulation of neurotrophin mRNA is an endogenous protective and/or repair mechanism induced by insult and, as such, appears as an early marker of peripheral nerve and muscle damage in experimental diabetes.